{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Medroxyprogesterone",
  "nciThesaurus": {
    "casRegistry": "520-85-4",
    "chebiId": "CHEBI:6715",
    "chemicalFormula": "C22H32O3",
    "definition": "A synthetic derivative of progesterone administered as an acetate salt (medroxyprogesterone acetate) with antiestrogenic activity. As a do all progestins, medroxyprogesterone binds to and activates nuclear receptors which subsequently bind to and activate target genes for transcription. As an antiestrogen, this agent may inhibit the growth-stimulating effects of estrogen on estrogen-sensitive tumor cells.",
    "fdaUniiCode": "HSU1C9YRES",
    "identifier": "C629",
    "preferredName": "Medroxyprogesterone",
    "semanticType": "Organic Chemical",
    "subclassOf": [
      "C776"
    ],
    "synonyms": [
      "(6Alpha)-17-hydroxy-6-methylpregn-4-ene-3,20-dione",
      "17Alpha-hydroxy-6alpha-methylprogesterone",
      "6Alpha-methyl-17alpha-hydroxyprogesterone",
      "6Alpha-methyl-4-pregnen-17alpha-ol-3,20-dione",
      "Curretab",
      "MEDROXYPROGESTERONE",
      "Medroxyprogesterone",
      "medroxyprogesterone"
    ]
  }
}